Ribosome subunits are upregulated in brain samples of a subgroup of individuals with schizophrenia: A systematic gene expression meta-analysis.

[1]  Joseph R. Scarpa,et al.  A study of gene expression in the living human brain , 2023, medRxiv.

[2]  F. McMahon,et al.  Antipsychotic drug use complicates assessment of gene expression changes associated with schizophrenia , 2023, Translational Psychiatry.

[3]  N. Sonenberg,et al.  Messenger RNA Translation Defects in Neurodegenerative Diseases. , 2023, The New England journal of medicine.

[4]  M. Owen.  Genomic insights into schizophrenia , 2023, Royal Society Open Science.

[5]  Shruti Thapliyal,et al.  Homeostatic plasticity and excitation-inhibition balance: The good, the bad, and the ugly , 2022, Current Opinion in Neurobiology.

[6]  M. Cuénod,et al.  Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia; Response to “Adaptive changes to oxidative stress in schizophrenia by Lena Palaniyappan” , 2022, Molecular Psychiatry.

[7]  Michael F. Green,et al.  Mapping genomic loci implicates genes and synaptic biology in schizophrenia , 2022, Nature.

[8]  K. Rosenblum,et al.  Somatostatin Interneurons of the Insula Mediate QR2-Dependent Novel Taste Memory Enhancement , 2021, eNeuro.

[9]  C. Hartl,et al.  Coexpression network architecture reveals the brain-wide and multiregional basis of disease susceptibility , 2021, Nature Neuroscience.

[10]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[11]  D. Ross,et al.  The diverse functionality of NQO1 and its roles in redox control , 2021, Redox biology.

[12]  E. Domany,et al.  Comprehensive Gene Expression Analysis Detects Global Reduction of Proteasome Subunits in Schizophrenia. , 2020, Schizophrenia bulletin.

[13]  Jennifer A. Erwin,et al.  Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids , 2020, Molecular Psychiatry.

[14]  Shuo Lin,et al.  The nuclear gene rpl18 regulates erythroid maturation via JAK2-STAT3 signaling in zebrafish model of Diamond–Blackfan anemia , 2020, Cell Death & Disease.

[15]  M. Berk,et al.  Impact of antipsychotic medication on IL‐6/STAT3 signaling axis in peripheral blood mononuclear cells of drug‐naive schizophrenia patients , 2020, Psychiatry and clinical neurosciences.

[16]  S. Srivastava,et al.  Repurposing Antipsychotics of the Diphenylbutylpiperidine Class for Cancer Therapy. , 2019, Seminars in cancer biology.

[17]  Kelsey S. Montgomery,et al.  CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder , 2019, Scientific Data.

[18]  Gary D. Bader,et al.  Single-cell transcriptomic profiling of the aging mouse brain , 2019, Nature Neuroscience.

[19]  David A. Lewis,et al.  Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder , 2019, Translational Psychiatry.

[20]  C. Ross,et al.  Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia. , 2019, The American journal of psychiatry.

[21]  D. Long,et al.  HIF-1α protects against oxidative stress by directly targeting mitochondria , 2019, Redox biology.

[22]  K. Rosenblum,et al.  PKR: A Kinase to Remember , 2019, Front. Mol. Neurosci..

[23]  Adrian Preda,et al.  Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium , 2018, Biological Psychiatry.

[24]  I. Melle,et al.  Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models , 2018, JAMA psychiatry.

[25]  P. Abete,et al.  Oxidative stress, aging, and diseases , 2018, Clinical interventions in aging.

[26]  Brian Kirkpatrick,et al.  Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups. , 2018, Journal of psychiatric research.

[27]  K. Rosenblum,et al.  Local Inhibition of PERK Enhances Memory and Reverses Age-Related Deterioration of Cognitive and Neuronal Properties , 2017, The Journal of Neuroscience.

[28]  Yohann Couté,et al.  Evidence for rRNA 2′-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes , 2017, Proceedings of the National Academy of Sciences.

[29]  Kaare Christensen,et al.  Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register , 2017, Biological Psychiatry.

[30]  Elijah F. W. Bowen,et al.  DLPFC transcriptome defines two molecular subtypes of schizophrenia , 2019, Translational Psychiatry.

[31]  Marc Recasens,et al.  The 40-Hz Auditory Steady-State Response in Patients With Schizophrenia: A Meta-analysis. , 2016, JAMA psychiatry.

[32]  Mila Ljujic,et al.  The integrated stress response , 2016, EMBO reports.

[33]  R. Ophoff,et al.  Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia , 2016, Schizophrenia Research.

[34]  Brittany N. Lasseigne,et al.  Post-mortem molecular profiling of three psychiatric disorders , 2016, bioRxiv.

[35]  Benjamin A. Logsdon,et al.  Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.

[36]  M. Passafaro,et al.  eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic Seizures , 2016, Cerebral cortex.

[37]  D. Smagin,et al.  Dysfunction in Ribosomal Gene Expression in the Hypothalamus and Hippocampus following Chronic Social Defeat Stress in Male Mice as Revealed by RNA-Seq , 2015, Neural plasticity.

[38]  I. Melle,et al.  Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium , 2016, Molecular Psychiatry.

[39]  W. van den Brink,et al.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. , 2015, Schizophrenia bulletin.

[40]  R. Gao,et al.  Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. , 2015, Current molecular medicine.

[41]  Eric E Schadt,et al.  A role for noncoding variation in schizophrenia. , 2014, Cell reports.

[42]  T. Woo,et al.  Molecular Profiles of Pyramidal Neurons in the Superior Temporal Cortex in Schizophrenia , 2014, Journal of neurogenetics.

[43]  Chunyu Liu,et al.  Two Gene Co-expression Modules Differentiate Psychotics and Controls , 2012, Molecular Psychiatry.

[44]  E. Klann,et al.  Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility. , 2012, Cell reports.

[45]  P. O’Donnell,et al.  Inhibitory interneurons, oxidative stress, and schizophrenia. , 2012, Schizophrenia bulletin.

[46]  Wei Huang,et al.  Suppression of PKR Promotes Network Excitability and Enhanced Cognition by Interferon-γ-Mediated Disinhibition , 2011, Cell.

[47]  Donghui Yan,et al.  Ribosomal protein RPL41 induces rapid degradation of ATF4, a transcription factor critical for tumour cell survival in stress , 2011, The Journal of pathology.

[48]  C. Davies,et al.  Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia , 2011, Journal of neuroscience research.

[49]  M. Barnes,et al.  Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function , 2009, Molecular Psychiatry.

[50]  J. McGrath,et al.  Schizophrenia: a concise overview of incidence, prevalence, and mortality. , 2008, Epidemiologic reviews.

[51]  B. Kennedy,et al.  Protein translation, 2007 , 2007, Aging cell.

[52]  R. Paz,et al.  Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. , 2006, The American journal of psychiatry.

[53]  P. Levitt,et al.  Critical Appraisal of DNA Microarrays in Psychiatric Genomics , 2006, Biological Psychiatry.

[54]  M. Toyota,et al.  Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. , 2006, International journal of molecular medicine.

[55]  K. Iwamoto,et al.  Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders , 2004, Molecular Psychiatry.

[56]  S. D. Nurbaev,et al.  Quantitation of Repetitive Sequences in Human Genomic DNA and Detection of an Elevated Ribosomal Repeat Copy Number in Schizophrenia: The Results of Molecular and Cytogenetic Analyses , 2003, Molecular Biology.

[57]  David A Lewis,et al.  Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.

[58]  J. Fleiss.  Review papers : The statistical basis of meta-analysis , 1993 .

[59]  L. Hedges.  Distribution Theory for Glass's Estimator of Effect size and Related Estimators , 1981 .

[60]  J. T. Webster,et al.  The Use of an F-Statistic in Stepwise Regression Procedures , 1972 .

[61]  Hong-sheng Liu,et al.  Drug resistance effects of ribosomal protein L24 overexpression in hepatocellular carcinoma HepG2 cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[62]  [Oxidative stress, rRNA genes, and antioxidant enzymes in pathogenesis of schizophrenia and autism: modeling and clinical advices]. , 2013, Zhurnal obshchei biologii.